Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Atovaquone/Proguanil Chemoprophylaxis
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 31 Mar 2017
At a glance
- Drugs Atovaquone/proguanil (Primary)
- Indications Malaria
- Focus Adverse reactions
- 29 Mar 2017 Planned End Date changed from 1 Oct 2018 to 1 Mar 2018.
- 29 Mar 2017 Planned primary completion date changed from 1 Oct 2018 to 1 Mar 2018.
- 29 Mar 2017 Status changed from not yet recruiting to active, no longer recruiting.